| Literature DB >> 21641209 |
Austin Chen1, Elizabeth Cauchon, Amandine Chefson, Sarah Dolman, Yves Ducharme, Daniel Dubé, Jean-Pierre Falgueyret, Pierre-André Fournier, Sébastien Gagné, Michel Gallant, Erich Grimm, Yongxin Han, Robert Houle, Jing-Qi Huang, Gregory Hughes, Hélène Jûteau, Patrick Lacombe, Sophie Lauzon, Jean-François Lévesque, Susana Liu, Dwight Macdonald, Bruce Mackay, Dan McKay, M David Percival, René St-Jacques, Sylvie Toulmond.
Abstract
The design and optimization of a novel series of renin inhibitor is described herein. Strategically, by committing the necessary resources to the development of synthetic sequences and scaffolds that were most amenable for late stage structural diversification, even as the focus of the SAR campaign moved from one end of the molecule to another, highly potent renin inhibitors could be rapidly identified and profiled.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21641209 DOI: 10.1016/j.bmcl.2011.05.014
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823